Skip to content
10-Q/A

Quarterly Report

Intellicell Biosciences, Inc.

0001013762-14-001206

← back to feed
Filed
Oct 9, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2014 · Mar 31, 2014 1.42B sh
Shares Diluted Q1 2014 · Mar 31, 2013 60.29M sh
Capex Q1 2014 · Mar 31, 2014 $0
Capex Q1 2014 · Mar 31, 2013 $4.27K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$1.52M
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$248.06K
Stockholders Equity restated Q1 2014 · Mar 31, 2014 −$16.86M
Stockholders Equity restated Q1 2014 · Dec 31, 2013 −$12.28M
Current Liabilities restated Q1 2014 · Mar 31, 2014 $5.83M
Current Liabilities restated Q1 2014 · Dec 31, 2013 $8.54M
Total Liabilities restated Q1 2014 · Mar 31, 2014 $20.96M
Total Liabilities restated Q1 2014 · Dec 31, 2013 $15.5M
Current Assets Q1 2014 · Mar 31, 2014 $1M
Current Assets Q1 2014 · Dec 31, 2013 $9K
Total Assets Q1 2014 · Mar 31, 2014 $4.1M
Total Assets Q1 2014 · Dec 31, 2013 $3.21M
Eps Diluted Q1 2014 · Mar 31, 2014 −$0.01
Eps Diluted Q1 2014 · Mar 31, 2013 −$0.02
Eps Basic Q1 2014 · Mar 31, 2014 −$0.01
Eps Basic Q1 2014 · Mar 31, 2013 −$0.02
Sga Expense restated Q1 2014 · Mar 31, 2014 $1.01M
Sga Expense Q1 2014 · Mar 31, 2013 $715.65K
Rd Expense Q1 2014 · Mar 31, 2014 $180K
Rd Expense Q1 2014 · Mar 31, 2013 $157.08K
Net Income restated Q1 2014 · Mar 31, 2014 −$10.24M
Net Income Q1 2014 · Mar 31, 2013 −$1.06M
Operating Income restated Q1 2014 · Mar 31, 2014 −$1.6M
Operating Income Q1 2014 · Mar 31, 2013 −$1.54M
Gross Profit Q1 2014 · Mar 31, 2014 $27.88K
Gross Profit Q1 2014 · Mar 31, 2013 $0
Cost Of Revenue Q1 2014 · Mar 31, 2014 $4.62K
Cost Of Revenue Q1 2014 · Mar 31, 2013 $0
Revenue Q1 2014 · Mar 31, 2014 $32.5K
Revenue Q1 2014 · Mar 31, 2013 $0
Shares Outstanding Q1 2014 · Nov 25, 2013 0 sh